Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Shanghai Mabgeek Biotech.co.ltd

Clinical trials sponsored by Shanghai Mabgeek Biotech.co.ltd, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New shot could soothe severe eczema in teens Results expected Jan 2027 (estimated)

Browse trials soon ready across all sponsors →

Not yet recruiting 3 Completed 1

Can a new antibody calm severe eczema?

Disease control Completed

This phase II trial is testing whether an experimental drug called MG-K10 can reduce the severity of moderate-to-severe atopic dermatitis, a chronic inflammatory skin condition. About 60 adults who have not responded well to topical treatments will receive either MG-K10 or a plac…

Phase 2 • Sponsor: Shanghai Mabgeek Biotech.Co.Ltd • Aim: Disease control

Last updated Aug 05, 2026 00:00 UTC